Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office

Rhea-AI Summary

Cellev8 Nutrition Inc (OTC PINK:CELV) has filed two patents at the US Trademark and Patent Office for its innovative supplement delivery systems. The patents focus on enhancing the transport of Superoxide Dismutase (SOD) and other ingredients throughout the body. The patent-pending formulations aim to improve absorption and utilization of key ingredients, particularly in their SOD formulations.

The company's delivery mechanisms have demonstrated effectiveness across thousands of users, targeting oxidative stress reduction and cellular protection. The technology will be applied across Cellev8's product range, including inflammation and recovery, focus and memory, and GLP1 support gummies. The company currently serves thousands of customers, including over 40 professional and collegiate athletic teams, and maintains partnerships with FDA-certified companies.

Positive

• Filed two patents to protect proprietary delivery systems technology
• Technology proven effective across thousands of users
• Serves over 40 professional and collegiate athletic teams
• Potential for collaborations with larger nutraceutical and pharmaceutical companies

Negative

• None.

WELLINGTON, FL / ACCESSWIRE / December 17, 2024 / Cellev8 Nutrition Inc (OTC PINK:CELV), a pioneer in Superoxide Dismutase (SOD) based supplements, has announced the filing of two patents to protect its groundbreaking delivery systems. These patents are set to revolutionize the company's product lines and enhance the proprietary transport of SOD and other powerful ingredients throughout the body to enhance wellness, and promote health and anti aging from cellular levels.

Advancing Supplement Technology

The patent-pending formulations represent a significant leap forward in supplement technology worldwide. Cellev8's delivery mechanisms have proven effect with thousands of people by focusing on reducing oxidative stress and providing superior cellular protection in the body. Cellev8 revolutionizes supplement effectiveness by employing advanced delivery mechanisms to enhance SOD absorption and combining it with powerful, targeted ingredients. This innovative approach maximizes the potency and precision of their products, delivering optimal benefits to specific areas of the body. These innovations are expected to further solidify the company's position as a leader in the wellness industry.

Key Highlights of the Patent Filings:

• Enhanced Ingredient Delivery: The new systems are designed to improve the absorption and utilization of key ingredients, including the company's flagship SOD formulations.

• Proprietary Transport Mechanisms: Cellev8's unique approach ensures that active compounds reach their intended targets more efficiently within the body.

• Broad Application: The patents cover delivery systems applicable across Cellev8's entire product range, including their popular inflammation and recovery gummies.

Impact on Product Lines

Michael Ferraro, CEO of Cellev8 Nutrition, commented on the patent filings: "These patents represent a culmination of our research and development efforts. They will not only protect our intellectual property but also pave the way for more effective and innovative wellness solutions for our customers. Imagine supplements that not only deliver powerful key ingredients more efficiently but also provides a precisely tailored blend of nutrients and critical anti-oxidants to support your body's unique needs. That's the Cellev8 difference! With our innovative approach, we're not just creating supplements - we're crafting personalized solutions for optimal health and vitality.."

The new delivery systems are expected to enhance the performance of Cellev8's existing products, including:

• Inflammation & Recovery Gummies

• Focus & Memory Gummies

• GLP1 Support Gummies

Future Prospects

With these patent filings, Cellev8 Nutrition is poised to expand its market presence with a lineup of additional products and potentially collaborate with larger nutraceutical and pharmaceutical companies interested in leveraging the benefits of their enhanced delivery process.

The company continues to focus on developing cutting-edge wellness products that promote health and vitality, serving thousands of customers, including over 40 professional and collegiate athletic teams, clients of FDA certified Zyppah products and patients/clients of publicly traded FDA approved sleep apnea company Vivos Therapeutics Inc.

For more information about Cellev8 Nutrition Inc and its innovative product line, visit www.cellev8.com

Contact Information

Michael Ferraro
CEO
mike@cellev8.com
561-578-0000

SOURCE: Cellev8 Nutrition Inc.

View the original press release on accesswire.com

FAQ

What patents did Cellev8 Nutrition (CELV) file in December 2024?

Cellev8 Nutrition filed two patents for their supplement delivery systems, specifically designed to enhance the transport of Superoxide Dismutase (SOD) and other ingredients throughout the body.

How will the new patents affect CELV's product line?

The patents will enhance the performance of Cellev8's existing products, including their Inflammation & Recovery, Focus & Memory, and GLP1 Support Gummies, by improving ingredient absorption and delivery efficiency.

What is the market reach of Cellev8 Nutrition (CELV)?

Cellev8 serves thousands of customers, including over 40 professional and collegiate athletic teams, and partners with FDA-certified Zyppah products and Vivos Therapeutics Inc.

What are the key features of CELV's patented delivery systems?

The delivery systems feature enhanced ingredient delivery, proprietary transport mechanisms, and broad application across their product range, focusing on improving absorption and utilization of SOD formulations.